Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Current Assets (2020 - 2025)

Historic Current Assets for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $624.0 million.

  • Relay Therapeutics' Current Assets fell 2787.04% to $624.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $624.0 million, marking a year-over-year decrease of 2787.04%. This contributed to the annual value of $809.2 million for FY2024, which is 507.74% up from last year.
  • Relay Therapeutics' Current Assets amounted to $624.0 million in Q3 2025, which was down 2787.04% from $680.4 million recorded in Q2 2025.
  • Over the past 5 years, Relay Therapeutics' Current Assets peaked at $1.1 billion during Q3 2022, and registered a low of $624.0 million during Q3 2025.
  • Its 5-year average for Current Assets is $818.7 million, with a median of $809.2 million in 2024.
  • As far as peak fluctuations go, Relay Therapeutics' Current Assets surged by 11568.58% in 2021, and later tumbled by 2787.04% in 2025.
  • Quarter analysis of 5 years shows Relay Therapeutics' Current Assets stood at $976.2 million in 2021, then rose by 4.43% to $1.0 billion in 2022, then fell by 24.46% to $770.1 million in 2023, then increased by 5.08% to $809.2 million in 2024, then fell by 22.89% to $624.0 million in 2025.
  • Its Current Assets stands at $624.0 million for Q3 2025, versus $680.4 million for Q2 2025 and $739.7 million for Q1 2025.